In the first place, antibiotic therapy is used depending on the sensitivity and resistance to the pathogen. But, often, they are used empirically, because in anticipation of the results obtained from this study, it takes up to several days and, when every minute counts and is expensive, they do not wait, as they increase the risk of death. The more pronounced the symptoms, the wider the spectrum of the applicable drug should be.tibiotic or a group of simultaneously applicable drugs. The principle of escalation and de-escalation is used.

The route of administration is preferred intravenous and, gradually transferring with a decrease in severe symptoms and aggravating factors, to oral. The duration of Hydroxychloroquine is 15-21 days. A phased treatment is applicable, for a more complete coverage of all the nuances of the pathology - acute bronchopneumonia.>

Semi-synthetics penicillins, cephalosporins, fluoroquinolone group, macrolides are applicable. Also aminoglycosides and tetracyclines, but in the most severe cases.

The selection of drugs for pathology is important. For example, catarrhal bronchopneumonia, which occurs from animals infected with pathogenic organisms, is not so common, but occurs in very severe forms. The use of a group of cephalosporins and carbapenems with powerful detox therapy is required, after a preliminary determination of the etiopathogenic pathogen from the animal. Additionally, detoxification measures are carried out: infusion infusions, oxygen therapy, bronchodilators, expectorants, antipyretics and NSAIDs, antipyretics, antiallergic, mucolytics, high-calorie foods, warm drinks, bronchoalveolar lavage, inhalation therapy with a nebulizer, motor mode in bed, vibration massage, immunoglobulin preparations, plasmapheresis, Exercise therapy, UHF therapy, herbal infusions and homeopathic supplements, warm foot baths, surgical treatment for serious complications.


Bronchopneumonia with adequate treatment is cured in 70% of cases, in 30% a complication develops.

plaquenil pill - differs in dry and fibrinous, with bronchopneumonia both types can occur. Recurrent obstructive processes. Abscesses - single or multiple. Bleeding from the lung, with ruptures or melting of the lung tissue. Pyopneumothorax, bronchial asthma, fibrinous changes (in addition to fibrinous pleurisy), multiple tissue destruction, necrosis - the death of parts of the lung tissue, which often creates a favorable background for lightning-fast seeding of infectious agents in unaffected areas of the lungs.

  • Extrapulmonary manifestations, are relatively less common than pulmonary, but still have a place to be. They, for the most part, are due to more rare mechanisms of penetration of etiopathogenetic agents - by the lymphogenous or hematogenous route.
  • In this context, the following nosologies are distinguishable: cardiovascular abnormal manifestations, myo-, peri-, endocarditis, infectious-toxic shock, purulent-bacterial pericarditis, septicemic phenomena, anemic manifestations of varying severity, psychosis and damage to the meninges in general, glomerulonephritis, damage to the urinary system and the excretion-filtration system of the kidneys, meningitis and meningisms.
  • Rationally selected therapeutic measures and, accordingly, applicable, timely initiated measures of the drug plan, prevent the development of the pathologies outlined above.
  • After recovery, it is mandatory to register with a therapist or pulmonologist for dispensary registration and active monitoring, prevention of relapses, rehabilitation and preventive measures applicable in a modern medical complex for at least six months for adults and 1 year for children.
  • It is important to remember that the pathology of bronchopneumonia, being the most common among other types of pneumonia, is cured most effectively in the early stages! In order to prevent complications and the development of concomitant consequences, pathological changes in all organ systems, it is worth seeking qualified medical help on time, without self-treatment and self-prescription of any drugs.

Newborns and infants under the age of three. Young children with idiopathic pathologies of the respiratory system. Children under the age of 12 with immunodeficiency. Elderly people over the age of 65. Smokers. Alcoholics. specific professional activity. Living in a polluted environment.


Full or partial immobilization. postoperative period. Cardiovascular diseases. Frequent pneumonia. Secondary immunodeficiency state. Long-term use of immunosuppressants. Chronic form of diseases of the bronchi and lungs. Anomalies of the respiratory system. Inflammation of the ENT organs in a chronic form. Diabetes mellitus of the first or second type.



Regardless of the type, bronchopneumonia, as an independent disease, most often develops in children and the elderly. In other cases, it manifests itself as a complication of other pathologies. Therefore, people at risk of illness should be more attentive to changes in the body. If there are abnormalities in the functionality of the respiratory system, you should immediately consult a doctor. This will prevent the development of acute bronchopneumonia and its complications.


Etiology of bronchopneumonia. The etiology of the disease is very multifaceted, but most often it is associated with changes in weather conditions. Basically, the disease manifests itself in the cold season and during the development of the epidemiological period. The etiopathogenetic mechanism for the development of bacterial pneumonia is associated with the presence of infectious processes in the body.

Wellness Services


The presence of infection in the bronchi, with its subsequent spread to the lungs. The impact of external infection on a weakened organism. long-term neurological disorder. Protracted depressive states and psychoses. Unbalanced diet and hypovitaminosis. Chronic pathologies in various forms. Systematic colds. Infection of the ENT organs.